This review summarizes the second-generation antipsychotics used as augmenting agents for the treatment of resistant major depressive disorder and the pharmacologic mechanisms involved in this combined...
Melinda S. Lantz, MD; Halina Kusz, MD, FACP; Anne Dohrenwend, PhD
When depression is diagnosed, it must be determined whether depression is affecting the patient’s decision-making capacity, particularly in end-of-life situations.
Eating disorders are chronic illnesses that often persist well into midlife and beyond, and include anorexia nervosa, bulimia nervosa, and pathologic binge eating.
